Innovation Proposals
Scientific Technological Center of Organic and Pharmaceutical Chemistry Scientific Technological Center of Organic and Pharmaceutical Chemistry
Division of Chemistry and Earth Sciences

Improvement of drug manufacturing conditions in the Scientific and Technological Centre of Organic and Pharmaceutical Chemistry and possibility of registration in new markets

N Investment project title Improvement of drug manufacturing conditions in the Scientific and Technological Centre of Organic and Pharmaceutical Chemistry and possibility of registration in new markets
1. Sector

Drug manufacturing

2. Project description

Currently in STCOPC 4 drugs with 5 formulations are manufactured, which are realized in the Republic of Armenia. Among them Gangleron is antispasmodic drug, used for treating cardiovascular abnormalities and manufactured in both vials and capsules form. Tiiodine is injection solution used for rheumatism treatment. Kaprofer is used for blood coagulation, mostly in dentistry. This drug is also very important for army needs as an emergency medicine during the war. 
In the STCOPC Ditiline medicine production is also designed, which has great demand in surgical practice. Currently, it is exported to Belarus and Ukraine. 
The Centre needs improvement in production of raw materials and dosage forms.

3. Project implementation period 2-3 years
4. Project location Scientific and Technological Centre of Organic and Pharmaceutical Chemistry of NAS RA
5. Project overall cost (USD) 1.230.094
6. Required investments (USD) 718.750
7. Own funds (USD) 511.344
8. Creation of jobs At the beginning of the project At the end of the project
30 20
9. Payback period 7-8 years
10. Annual profitability index 40.000.000 AMD - (USD 83.335)
11. Detailed costs

Development of modern conditions for drug’s raw material manufacturing - 200 million AMD
Development of modern conditions for drug formulation and granulation - 70 million AMD
Registration of drugs in new markets and their promotion - 75 million AMD

12. Offer to investor

-

13. Contact details

Vigen Topuzyan, Director of the Scientific and Technological Centre of Organic and Pharmaceutical Chemistry of NAS RA
E-mail: vtop {[ at ]} web.am
Tel.: (+374 10) 288334



Medical drugs produced by Scientific-technological centre of organic and pharmaceutical chemistry NAS RA
Medical drugs produced by Scientific-technological centre of organic and pharmaceutical chemistry NAS RA